Health Insurance
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
Despite FDA advisory support, CMS excludes Galleri from coverage, forcing patients to pay out-of-pocket while awaiting a 2029 policy shift.
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
Star Health’s ₹780 Crore Cancer Payouts Signal Rising Claims Burden for Policyholders
Insurer settles 85,900 cancer claims in H1 FY27, with women and the 51-60 age group driving a 17% surge in payouts.
-
Four in 10 US Adults Carry Health Care Debt as Michigan Wipes Another $21 Million
Learn how insured patients can navigate hospital billing departments, leverage legal protections, and manage unexpected medical debt.
-
Medicare Advantage Agents Earn Up to $725 per Enrollment While Original Medicare Pays Nothing
Federal caps allow agents to earn hundreds for Medicare Advantage sign-ups while paying nothing for Original Medicare recommendations.
-
The Growing Financial and Regulatory Realities of Concierge Medicine Models
As concierge practices surge in popularity, patients and providers must navigate complex Medicare rules regarding membership fees and covered services.
-
Blue Cross Blue Shield Association Ties Hospital AI Coding Tools to $942 Million in Added Costs
BERKELEY, September 27 — Artificial intelligence tools used in medical billing and claims processing pushed patient costs up by nearly $1 billion…
-
Moral Hazard Shapes Insurance Decisions, Even for Lifestyle Drugs
MANILA, July 22 — The concept known as moral hazard quietly shapes decisions that affect families across Asia every day, from health…
-
UnitedHealth Expands Coverage for Non-Invasive Colorectal Cancer Blood Test
NEW YORK, July 1 — UnitedHealth Group has added Guardant Health’s Shield blood test to its coverage list for colorectal cancer screening,…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992









